0
Détail de l'éditeur
|
Documents disponibles chez cet éditeur (13)
Ajouter le résultat dans votre panier Affiner la recherche
Titre : Analysis of refill liquids for electronic cigarettes Type de document : texte imprimé Auteurs : Jean-François Etter, Auteur ; Eva Zäther, Auteur ; Sofie Svensson, Auteur Editeur : Society for the study of addiction to alcohol and other drugs Année de publication : 2013 Collection : Addiction num. 108(9) Importance : p.1671-1679 Langues : Anglais (eng) Catégories : [TABAC] chimie du tabac:constituant:alcaloïde:nicotine
[TABAC] chimie du tabac:tabac fumé:cigarette:cigarette électroniqueIndex. décimale : TA 1.1.1 Cigarettes (« normales », électroniques, aromatisées,…) Résumé : Aims
To assess levels of nicotine, nicotine degradation products and some specific impurities in commercial refill liquids for electronic cigarettes.
Design and setting
We analyzed 20 models of 10 of the most popular brands of refill liquids, using gas and liquid chromatography.
Measurements
We assessed nicotine content, content of the known nicotine degradation products and impurities, and presence of ethylene glycol and diethylene glycol.
Findings
The nicotine content in the bottles corresponded closely to the labels on the bottles. The levels of nicotine degradation products represented 0–4.4% of those for nicotine, but for most samples the level was 1–2%. Cis-N-oxide, trans-N-oxide, myosmine, anatabine and anabasine were the most common additional compounds found. Neither ethylene glycol nor diethylene glycol were detected.
Conclusion
The nicotine content of electronic cigarette refill bottles is close to what is stated on the label. Impurities are detectable in several brands above the level set for nicotine products in the European Pharmacopoeia, but below the level where they would be likely to cause harm.En ligne : http://onlinelibrary.wiley.com/doi/10.1111/add.12235/abstract Format de la ressource électronique : HTML et PDF (payant) Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=7599 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Back to the drawing board? A review of applications of the transtheoretical model to substance use / Stephen Sutton (2001)
Titre : Back to the drawing board? A review of applications of the transtheoretical model to substance use Type de document : texte imprimé Auteurs : Stephen Sutton, Auteur Editeur : Society for the study of addiction to alcohol and other drugs Année de publication : 2001 Collection : Addiction num. 96 (1) Importance : p. 175-186 Langues : Anglais (eng) Catégories : [TABAC] sevrage tabagique:méthode de sevrage:méthode individuelle:approche psychologique:entretien motivationnel:modèle transthéorique
[TABAC] tabagisme:aspect psychologique:comportementIndex. décimale : TA 6.2.2.1 Méthode comportementale Résumé : The transtheoretical model (TTM) is still enormously popular with practitioners, clinicians and many researchers in the addictions . eld. However, in a recent years a number of commentators have criticized aspects of the model and the research based on it. This paper extends a recent critique of the TTM as applied to smoking cessation to include applications of the model to cessation or reduction of alcohol or drug use. The . rst section discusses measures of the central construct of stages of change and notes a number of serious problems. Staging algorithms are based on arbitrary time periods and some are logically awed. In the case of multi-dimensional questionnaires (the URICA, the SOCRATES and the RCQ), the pattern of correlations among the subscales shows that they are not measuring discrete stages of change. The one study to date that has compared the two different methods found low concordance, which is probably due to incompatible stage de. nitions. In the second section of the paper, the evidence base for the TTM is reviewed. The review is organized by the four research designs that have been used to test predictions from stage models: cross-sectional comparisons of people in different stages examination of stage sequences longitudinal prediction of stage transitions and experimental studies of matched and mismatched interventions. It concludes that current evidence for the model as applied to substance use is meagre and inconsistent. Researchers are urged to develop better stage models. Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=1413 Exemplaires (1)
Code-barres Cote Support Localisation Section Disponibilité TA 002432 TA 6.2.2.1 SUT B Article/Périodique Bibliothèque FARES Tabac Consultation sur place
Exclu du prêtAucun avis, veuillez vous identifier pour ajouter le vôtre !
Clinical laboratory assessment of the abuse liability of an electronic cigarette / Andrea R. Vansickel (2012)
Titre : Clinical laboratory assessment of the abuse liability of an electronic cigarette Type de document : document électronique Auteurs : Andrea R. Vansickel, Auteur ; Michael F. Weave, Auteur ; Thomas Eissenberg, Auteur Editeur : Society for the study of addiction to alcohol and other drugs Année de publication : 2012 Collection : Addiction num. 107 Importance : p. 1493-1500 Présentation : graph. Langues : Anglais (eng) Catégories : [TABAC] chimie du tabac:fumée
[TABAC] tabagisme:évaluation du tabagisme:test médicalIndex. décimale : TA 1.1.1 Cigarettes (« normales », électroniques, aromatisées,…) Résumé : OBJECTIFS:
Fournir une évaluation initiale de la responsabilité en matière d’abus d’une cigarette électronique chez les fumeurs de cigarettes au tabac.
CONCEPTION:
La première des quatre sessions intra-sujet était une session d'échantillonnage EC comprenant six combats de 10 bouffées (intervalle de 30 secondes entre les bouffées), chacun d'eux étant séparé de 30 minutes. Au cours des trois sessions restantes, les participants ont choisi entre 10 bouffées et différentes quantités d’argent, 10 bouffées pour la CE et un nombre varié de bouffées de cigarettes de marque propre, ou 10 bouffées d’OB et des sommes variables en utilisant la procédure à choix multiples ( MCP). Le MCP a été complété six fois à des intervalles de 30 minutes et un choix a été renforcé au hasard à chaque essai.
RÉGLAGE:
Laboratoire clinique.
PARTICIPANTS:
Vingt fumeurs actuels de cigarettes au tabac.
DES MESURES:
Les résultats de la séance d’échantillonnage comprenaient la nicotine plasmatique, la réponse cardiovasculaire et les effets subjectifs. Le résultat de la session Choice était la valeur croisée sur le MCP.
RÉSULTATS:
L'utilisation par les CE a entraîné une libération significative de nicotine, une suppression des symptômes de l'abstinence du tabac et une augmentation de l'acceptabilité des produits. Sur le MCP, les participants ont choisi de recevoir 10 bouffées CE sur une moyenne de 1,06 $ ou trois bouffées OB et ont choisi 10 bouffées OB sur une moyenne de 1,50 $ (P <0,003).
CONCLUSIONS:
Les cigarettes électroniques peuvent libérer des quantités cliniquement significatives de nicotine et réduire les symptômes d’abstinence des cigarettes. Elles semblent moins risquer d’être maltraitées par rapport aux cigarettes à tabac traditionnelles, du moins dans certaines conditions de laboratoire.En ligne : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3330136/ Format de la ressource électronique : HTML, PDF Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=8886 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Comparative efficacy of 24-hour and 16-hour transdermal nicotine patches for relief of morning craving / Saul Shiffman (2000)
Titre : Comparative efficacy of 24-hour and 16-hour transdermal nicotine patches for relief of morning craving Type de document : document électronique Auteurs : Saul Shiffman, Auteur ; C.A. Elash, Auteur ; Stephanie M. Paton, Auteur ; Chad J. Gwaltney, Auteur ; Jean A. Paty, Auteur ; D.B. Clarke, Auteur ; K.S. Liu, Auteur ; Michael E. Di Marino, Auteur Editeur : Society for the study of addiction to alcohol and other drugs Année de publication : 2000 Collection : Addiction num. 95(8) Importance : p.1185-1195 Langues : Anglais (eng) Catégories : [TABAC] sevrage tabagique:efficacité du sevrage
[TABAC] sevrage tabagique:méthode de sevrage:méthode individuelle:approche pharmacologique:patch à la nicotineIndex. décimale : TA 6.2.3.1.2 Transcutané Résumé : Aims: To compare a transdermal nicotine patch designed for 24-hour wear with one designed for 16-hour wear for relief of craving and withdrawal, particularly in the morning hours.
Design: Smokers were randomly assigned to use one of two common patch regimens: NicoDerm/NiQuitin (24-hour wear, 21 mg nicotine) or Nicotrol/Nicorette (16-hour wear, 15 mg). In a double-dummy design, participants wore two patches during the day, one active, one placebo and one patch while sleeping.
Setting: A smoking cessation research clinic.
Participants: Two hundred and forty-four smokers who suffered morning cravings.
Intervention: Two patch formulations approved and marketed for over-the-counter use in the US--NicoDerm CQ (labeled as 21 mg over 24 hours) and Nicotrol (labeled as 15 mg over 16 hours)--were each used according to its instructions. Smokers also received behavioral counseling.
Measurements: For a week of baseline and 2 weeks after quitting, smokers used palm-top computers to assess craving and withdrawal symptoms several times each day.
Findings: The 21 mg/24-hour patch yielded consistently better control of craving, not only during the morning hours, but throughout the day, and over the 2-week period of abstinence. Additionally, the 21 mg/24-hour patch yielded greater reductions in anxiety, irritability and restlessness. Smokers using the 21 mg/24-hour dosing regimen also experienced longer abstinence than those using the 15 mg/16-hour patch.
Conclusions: These findings demonstrate that 24-hour dosing with a 21 mg patch affords superior relief of craving and withdrawal during the first 2 weeks of abstinence, when symptoms are at their peak, and when relapse is most likely. They confirm the importance of dosing parameters in nicotine replacement products.En ligne : https://doi.org/10.1046/j.1360-0443.2000.95811855.x Format de la ressource électronique : Article en ligne Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=10343 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Do the transtheoretical model process of change, decisional balance and temptation predict stage movement ? Evidence from smoking cessation in adolescents / Boliang Guo (2009)
Titre : Do the transtheoretical model process of change, decisional balance and temptation predict stage movement ? Evidence from smoking cessation in adolescents Type de document : texte imprimé Auteurs : Boliang Guo, Auteur ; Paul Aveyard, Auteur ; Antony Fielding, Auteur ; Stephen Sutton, Auteur Editeur : Society for the study of addiction to alcohol and other drugs Année de publication : 2009 Collection : Addiction num. 104 (5) Importance : p.828-838 Catégories : [DIVERS] personne:famille:adolescent
[TABAC] sevrage tabagique
[TABAC] sevrage tabagique:méthode de sevrage:méthode individuelle:approche psychologique:entretien motivationnel:modèle transthéorique
[TABAC] tabagisme:aspect psychologique:comportementIndex. décimale : TA 6.2.2.1 Méthode comportementale Résumé : AIMS: To examine the effects of processes of change (POC) on forward stage movement directly, indirectly through decisional balance and temptation, and total effects as a test of the key hypothesis of the Transtheoretical Model (TTM). DESIGN: Prospective cohort study. SETTING: United Kingdom. PARTICIPANTS: A total of 1160 adolescents aged 13-14 years who were current or former smokers at baseline. MEASUREMENTS: Stage was assessed with the standard algorithm three times, once every 3 months. On each occasion the POC, decisional balance and temptation were measured with the standard questionnaires. Path analysis was used to examine the direct, indirectly mediated and total contribution of POC and the other constructs to stage movement 3 months later. FINDINGS: Four of the 24 analyses showed evidence that the theoretically appropriate POC predicted stage transition, with statistically significant total effects. Effect sizes were small. When the POC were summarized to experiential and behavioural process means, one transition from pre-contemplation was predicted by experiential processes and, contrary to the TTM, one transition predicted by behavioural processes. There was slightly more evidence that decisional balance (attitudes towards smoking) and temptation (ability to resist the urge to smoke) was associated with stage transition. CONCLUSIONS: POC use was not associated generally with stage transition and evidence that effects, if missed, must be modest, giving no support to the central tenet of the TTM. Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=1414 Exemplaires (1)
Code-barres Cote Support Localisation Section Disponibilité TA 002433 TA 6.2.2.1 GUO D Article/Périodique Bibliothèque FARES Tabac Consultation sur place
Exclu du prêtAucun avis, veuillez vous identifier pour ajouter le vôtre !
Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice / J.A. Stapleton (1995)
Titre : Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice Type de document : texte imprimé Auteurs : J.A. Stapleton, Auteur ; M.A.H. Russel, Auteur ; C. Feyerabend, Auteur ; S.M. Wiseman, Auteur ; G. Gustavsson, Auteur ; U. Sawe, Auteur ; D. Wiseman, Auteur Editeur : Society for the study of addiction to alcohol and other drugs Année de publication : 1995 Collection : Addiction num. 90 Importance : p. 31-42 Catégories : [TABAC] étude:recherche:recherche clinique
[TABAC] étude:recherche:recherche clinique:essai clinique randomisé
[TABAC] sevrage tabagique
[TABAC] sevrage tabagique:aide au sevrage
[TABAC] sevrage tabagique:méthode de sevrage:méthode individuelle:approche pharmacologique:patch à la nicotine
[TABAC] sevrage tabagique:méthode de sevrage:méthode individuelle:approche pharmacologique:substitution nicotinique
[TABAC] tabagisme
[TABAC] tabagisme:effet du tabacIndex. décimale : TA 6.2.3.1.2 Transcutané Résumé : Le patch à la nicotine est reconnu comme une aide efficace dans le sevrage tabagique. La facilité et la sécurité du traitement lui donne un avantageux potentiel sur le chewing-gum nicotinique comme adjoint dans les soins primaires que l'on peut mettre en place dans le domaine de la santé publique. Cette étude tente de le démontrer à l'aide d'une enquête basée sur des expériences pratiques. Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=1408 Exemplaires (1)
Code-barres Cote Support Localisation Section Disponibilité TA 000164 TA 6.2.3.1.2 STA D Article/Périodique Bibliothèque FARES Tabac Consultation sur place
Exclu du prêtAucun avis, veuillez vous identifier pour ajouter le vôtre !
Effect of smoking cessation counseling on recovery from alcoholism / J.K. Bobo (1998)
Titre : Effect of smoking cessation counseling on recovery from alcoholism : findings from a randomized community intervention trial Type de document : texte imprimé Auteurs : J.K. Bobo, Auteur ; H.E. Mcllvain, Auteur ; H.A. Lando, Auteur ; R.D. Walker, Auteur ; A. Leed-Kelly, Auteur Editeur : Society for the study of addiction to alcohol and other drugs Année de publication : 1998 Collection : Addiction num. 93 (6) Importance : p. 877-887 Note générale : biblio. Catégories : [TABAC] étude
[TABAC] étude:recherche:recherche clinique:essai clinique randomisé
[TABAC] sevrage tabagique
[TABAC] tabagisme
[TABAC] tabagisme:risque:facteur associé:alcoolIndex. décimale : TA 0.1.1 Congrès, conférence et colloque Résumé : L'article évoque les effets du sevrage tabagique sur le sevrage d'alcool, en étudiant un groupe de participant. Ce n'est pas concluant. Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=1409 Exemplaires (1)
Code-barres Cote Support Localisation Section Disponibilité TA 000485 TA 0.1.1 SMO S Article/Périodique Bibliothèque FARES Tabac Consultation sur place
Exclu du prêtAucun avis, veuillez vous identifier pour ajouter le vôtre !
A randomized controlled trial of a smoking cessation intervention based in community pharmacies / T.A. Maguire (2001)
Titre : A randomized controlled trial of a smoking cessation intervention based in community pharmacies Type de document : texte imprimé Auteurs : T.A. Maguire, Auteur ; J.C. McElnay, Auteur ; A. Drummond, Auteur Editeur : Society for the study of addiction to alcohol and other drugs Année de publication : 2001 Collection : Addiction num. 96 Importance : p. 325-331 Présentation : tab. Langues : Anglais (eng) Catégories : [DIVERS] géographie:Europe:Europe occidentale:Irlande
[TABAC] étude
[TABAC] prévention:santé:éducation pour la santé:rôle du professionnel de santé
[TABAC] sevrage tabagique:aide au sevrage:conseil de sevrageIndex. décimale : TA 0.3.3 Dentistes et pharmaciens Résumé : AIMS:
To evaluate whether a structured community pharmacy-based smoking cessation programme (the PAS model) would give rise to a higher smoking cessation rate compared with ad hoc advice from pharmacists.
DESIGN:
A randomized controlled trial comparing a structured intervention with usual care.
SETTING:
One hundred pharmacists working in community pharmacies in N. Ireland and 24 in London took part in the study and were each asked to enroll 12 smokers; 44% of pharmacists who were trained managed to recruit one or more smokers during the recruitment period of approximately 1 year.
PARTICIPANTS:
A total of 484 smokers were enrolled by the pharmacists and individually randomized into the PAS intervention group (N = 265) or the control group (N = 219).
INTERVENTION:
The PAS intervention involved a structured counselling programme, an information leaflet and a follow-up weekly for the first 4 weeks then monthly as needed.
MEASUREMENTS:
The primary outcome measure of this study was self-reported smoking cessation for 12 months with cotinine validation at the 12-month follow-up.
FINDINGS:
Of smokers in the PAS group, 14.3% (38) were abstinent up to 12 months compared with 2.7% (6) in the control group (p < 0.001 for the difference).
CONCLUSION:
The community pharmacy-based PAS smoking cessation service can be an effective method of helping people stop smoking when delivered by pharmacists willing to adopt this approach.Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=8136 Exemplaires (1)
Code-barres Cote Support Localisation Section Disponibilité TA 005713 0.3.3 MAG R Article/Périodique Bibliothèque FARES Tabac Consultation sur place
Exclu du prêtAucun avis, veuillez vous identifier pour ajouter le vôtre !
Real-world efficacy of prescription and over-the-counter nicotine replacement therapy / Saul Shiffman (2001)
Titre : Real-world efficacy of prescription and over-the-counter nicotine replacement therapy Type de document : document électronique Auteurs : Saul Shiffman, Auteur ; Clyde N. Rolf, Auteur ; Stephen J. Hellebusch, Auteur ; Jane Gorsline, Auteur ; W. Gorodetzky, Auteur ; Yu-Kun Chiang, Auteur ; Debra S. Schleusener, Auteur ; Michael E. Di Marino, Auteur Editeur : Society for the study of addiction to alcohol and other drugs Année de publication : 2001 Collection : Addiction num. 97 Importance : p.505-516 Langues : Anglais (eng) Catégories : [TABAC] sevrage tabagique:méthode de sevrage:méthode individuelle:approche pharmacologique:chewing-gum
[TABAC] sevrage tabagique:méthode de sevrage:méthode individuelle:approche pharmacologique:patch à la nicotine
[TABAC] sevrage tabagique:méthode de sevrage:méthode individuelle:approche pharmacologique:substitution nicotiniqueIndex. décimale : TA 6.2.3.1 Substitution nicotinique Résumé : Aims To assess smoking cessation rates achieved with nicotine gum and patch in simulated over-the-counter (OTC) and actual prescription (Rx) settings.
Design Separate open-label studies with gum and patch in OTC and Rx settings.
Participants There were multiple samples: OTC gum: 2981 smokers; OTC patch: 2367; Rx gum: 324; Rx patch: 669.
Interventions All smokers received active nicotine replacement. In the OTC setting, smokers self-selected doses of nicotine gum (2 or 4mg Nicorette®) or patch (21, 14 or 7mg NicoDerm® CQ). No intervention was provided. In the Rx setting, smokers were prescribed gum or patch by their physician.
Measurements Biochemically verified continuous smoking abstinence was assessed at 6 weeks (28-day abstinence) and 6 months.
Findings OTC success rates were consistently higher than Rx rates: differences were significant at 6 weeks for both patch [OR = 1.45 (1.05–1.98)] and gum [OR = 2.92 (1.58–5.40)], and remained significant at 6 months for patch [OR = 3.63; (1.74–7.61)] but not gum [OR = 1.37; (0.73–2.58)]. Among OTC gum users, 16.1% were abstinent at 6 weeks and 8.4% at 6 months. For Rx gum users, abstinence rates were 7.7% at 6 weeks and 7.7% at 6 months. With OTC patch, 19.0% were abstinent at 6 weeks and 9.2% at 6 months. With Rx patch, abstinence rates were 16.0% at 6 weeks and 3.0% at 6 months.
Conclusions Smoking cessation rates achieved with nicotine gum and patch under OTC conditions were as good as those under real-world prescribing conditions.
En ligne : https://doi.org/10.1046/j.1360-0443.2002.00141.x Format de la ressource électronique : Article en ligne Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=10342 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Shape of the relapse curve and long-term abstinence among untreated smokers / John R. Hughes (20/04/2005)
Titre : Shape of the relapse curve and long-term abstinence among untreated smokers Type de document : texte imprimé Auteurs : John R. Hughes, Auteur ; Josue Keely, Auteur ; Shelly Naud, Auteur Editeur : Society for the study of addiction to alcohol and other drugs Année de publication : 20/04/2005 Collection : Addiction num. 99 Importance : p. 29-38 Note générale : Dans la bibliothèque virtuelle (articles scientifiques) Catégories : [TABAC] sevrage tabagique
[TABAC] sevrage tabagique:efficacité du sevrage:rechuteIndex. décimale : TA 6.5 Rechutes Résumé : Objective : To describe the relapse curve and rate of long-term prolonged abstinence among smokers who try to quit without treatment. Results : There is a paucity of studies reporting relapse curves of self-quitters. The existing eight relapse curves from two studies of self-quitters and five notreatment control groups indicate most relapse occurs in the first 8 days. These relapse curves were heterogeneous even when the final outcome was made similar. In terms of prolonged abstinence rates, a prior summary of 10 self-quitting studies, two other studies of self-quitters and three no-treatment control groups indicate 3–5% of self-quitters achieve prolonged abstinence for 6–12 month after a given quit attempt. Conclusions : More reports of relapse curves of self-quitters are needed. Smoking cessation interventions should focus on the first week of abstinence. Interventions that produce abstinence rates of 5–10% may be effective. Cessation studies should report relapse curves. En ligne : https://doi.org/10.1111/j.1360-0443.2004.00540.x Format de la ressource électronique : Article en ligne Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=1411 Exemplaires (1)
Code-barres Cote Support Localisation Section Disponibilité TA 002104 TA 6.5 HUG S Article/Périodique Bibliothèque FARES Tabac Consultation sur place
Exclu du prêtAucun avis, veuillez vous identifier pour ajouter le vôtre !
Smoking reduction promotes smoking cessation: results from a double blind, randomized, placebo-controlled trial of nicotine gum with 2-year follow-up / Poul Wennike (2003)
Titre : Smoking reduction promotes smoking cessation: results from a double blind, randomized, placebo-controlled trial of nicotine gum with 2-year follow-up Type de document : texte imprimé Auteurs : Poul Wennike, Auteur ; Tobias Danielsson, Auteur ; Björn Landfeldt, Auteur ; A. Westin, Auteur ; Philip Tonnesen, Auteur Editeur : Society for the study of addiction to alcohol and other drugs Année de publication : 2003 Collection : Addiction num. 98 Importance : p.1395-1402 Langues : Anglais (eng) Catégories : [TABAC] étude
[TABAC] sevrage tabagique:efficacité du sevrage:motivation
[TABAC] sevrage tabagique:méthode de sevrage:méthode individuelle:approche pharmacologique:chewing-gum
[TABAC] sevrage tabagique:méthode de sevrage:méthode individuelle:approche pharmacologique:placeboIndex. décimale : TA 6.2.3.1.1 Chewing-gum Résumé :
Aim To test the effect of nicotine gum and placebo in smokers not motivated or not able to quit smoking with regard to smoking reduction and smoking cessation.
Design This randomized study evaluated nicotine gum versus placebo for up to 1 year in 411 healthy smokers highly motivated to reduce cigarette use. Smoking reduction was defined as self-reported daily smoking less than 50% of baseline and any decrease (1 p.p.m. or more) in carbon monoxide.
Setting Pulmonary department, Copenhagen, Denmark.
Findings The overall success rate for sustained smoking reduction was significantly higher at all time-points for active versus placebo gum (6.3% versus 0.5% after 24 months). Nicotine gum achieved significantly higher point prevalence cessation rates than placebo at 12 and 24 months [11.2% versus 3.9% (odds ratio = 3.1; 95% CI, 1.4–7.2 and 9.3% versus 3.4% (odds ratio = 2.9; 95% CI, 1.2–7.1), respectively]. There was a linear relationship between decrease in number of daily cigarettes and decrease in plasma cotinine, exhaled carbon monoxide and plasma thiocyanate, with significantly greater reduction in the nicotine gum group after 4 and 12 months (maximum treatment duration) but not after 24 months. The decrease in toxin intake was smaller than the decline in daily cigarette consumption, suggesting that compensatory smoking occurred.
Conclusions Nicotine gum promoted cessation in this population of smokers unwilling to quit. Among reducers, the toxin intake correlated with reduced cigarette consumption although some compensatory smoking occurred.
Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=10327 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre : Symptoms of nicotine dependence in a cohort of Swedish youths : a comparison between smokers, smokeless tobacco users and dual tobacco users Type de document : texte imprimé Auteurs : Ann Post, Auteur ; Hans Gilljam, Auteur ; Ingvar Rosendhal, Auteur ; Sven Bremberg, Auteur ; Maria Rosaria Galanti, Auteur Editeur : Society for the study of addiction to alcohol and other drugs Année de publication : 2010 Collection : Addiction num. 105:4 Importance : 7 p. Présentation : tab. Langues : Anglais (eng) Catégories : [DIVERS] géographie:Europe:Europe du Nord:Suède
[TABAC] chimie du tabac:tabac non fumé:tabac à sucer:snus
[TABAC] étude:enquête
[TABAC] tabagisme:évaluation du tabagisme:test médicalIndex. décimale : TA 4.2.2.1 Dépendance à la nicotine Résumé : AIMS:
To determine whether symptoms of nicotine dependence, addiction and withdrawal symptoms differ between exclusive smokers, exclusive snus (moist snuff) users and dual users.
DESIGN:
A cross-sectional survey of a cohort subsample. Setting County of Stockholm, Sweden.
PARTICIPANTS:
Current exclusive smokers (n = 466), exclusive snus users (n = 209) and dual users (n = 144), mean age 17.6 years.
MEASUREMENTS:
Self-reported life-time experience of nicotine dependence and withdrawal symptoms in periods of discontinued tobacco use. Selected items from the modified Fagerstöm Tolerance Questionnaire (mFTQ), the Hooked on Nicotine Checklist (HONC) and the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV).
FINDINGS:
The odds ratio of endorsing each of four mFTQ items as well as the HONC item investigating the risk of feeling addicted to tobacco was two to five-fold higher for exclusive snus users and for dual users compared to exclusive smokers. One DSM-IV item (difficult to refrain from use) was elevated among dual users compared to smokers. Dual users reported the highest prevalence of any withdrawal symptom in contrast to exclusive snus users, who reported a lower risk of withdrawal symptoms compared to exclusive smokers.
CONCLUSIONS:
Smokeless tobacco users show symptoms of nicotine dependence at least as frequently as cigarette smokers. Symptoms of nicotine dependence and of withdrawal during quit attempts are particularly frequent in the subgroup of users who combine smokeless tobacco with smoking.En ligne : https://www.researchgate.net/publication/41423196_Symptoms_of_nicotine_dependenc [...] Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=8135 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre : Time for a change : putting the transtheoretical (stages of change) model to rest Type de document : texte imprimé Auteurs : Robert West, Auteur ; Thaddeus A. Herzog, Auteur ; Jean-François Etter, Auteur ; David C. Hodgins, Auteur ; Stephen Sutton, Auteur ; Carlo C. Diclemente, Auteur Editeur : Society for the study of addiction to alcohol and other drugs Année de publication : 2005 Collection : Addiction num. 100 (8) Importance : p. 1036-1039 Langues : Anglais (eng) Catégories : [TABAC] sevrage tabagique:méthode de sevrage:méthode individuelle:approche psychologique:entretien motivationnel:modèle transthéorique
[TABAC] tabagisme:aspect psychologique:comportementIndex. décimale : TA 6.2.2.1 Méthode comportementale Résumé : Argumentations en faveur de l'abandon du modèle transthéorique, et commentaires En ligne : https://onlinelibrary.wiley.com/doi/epdf/10.1111/j.1360-0443.2005.01139.x Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=1412 Aucun avis, veuillez vous identifier pour ajouter le vôtre !